BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 12841812)

  • 1. Valsartan-induced angioedema.
    Irons BK; Kumar A
    Ann Pharmacother; 2003; 37(7-8):1024-7. PubMed ID: 12841812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II receptor blocker-induced angioedema in the oral floor and epiglottis.
    Shino M; Takahashi K; Murata T; Iida H; Yasuoka Y; Furuya N
    Am J Otolaryngol; 2011; 32(6):624-6. PubMed ID: 21324549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valsartan-induced angioedema in a patient on angiotensin-converting enzyme inhibitor for years: case report and literature review.
    Kalra A; Cooley C; Palaniswamy C; Kalra A; Zanotti-Cavazzoni SL
    Am J Ther; 2012 Nov; 19(6):e189-92. PubMed ID: 20838200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olmesartan medoxomil-induced angioedema.
    Nykamp D; Winter EE
    Ann Pharmacother; 2007 Mar; 41(3):518-20. PubMed ID: 17341528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angioedema and photosensitive rash induced by valsartan.
    Frye CB; Pettigrew TJ
    Pharmacotherapy; 1998; 18(4):866-8. PubMed ID: 9692664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angioedema associated with candesartan.
    Lo KS
    Pharmacotherapy; 2002 Sep; 22(9):1176-9. PubMed ID: 12222554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease.
    Ruilope LM; Aldigier JC; Ponticelli C; Oddou-Stock P; Botteri F; Mann JF
    J Hypertens; 2000 Jan; 18(1):89-95. PubMed ID: 10678548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angioedema associated with angiotensin II receptor antagonists: challenging our knowledge of angioedema and its etiology.
    Chiu AG; Krowiak EJ; Deeb ZE
    Laryngoscope; 2001 Oct; 111(10):1729-31. PubMed ID: 11801934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valsartan. Just a second-line antihypertensive drug.
    Can Fam Physician; 1999 Nov; 45():2626-8, 2630-3. PubMed ID: 10587770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angioedema due to valsartan.
    Martínez Alonso JC; Domínguez Ortega FJ; Méndez Alcalde J; Fuentes Gonzalo MJ
    Allergy; 2003 Apr; 58(4):367. PubMed ID: 12708991
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug-induced isolated visceral angioneurotic edema.
    Arakawa M; Murata Y; Rikimaru Y; Sasaki Y
    Intern Med; 2005 Sep; 44(9):975-8. PubMed ID: 16258215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of valsartan added to background ACE inhibitor therapy in patients with heart failure: results from Val-HeFT.
    Krum H; Carson P; Farsang C; Maggioni AP; Glazer RD; Aknay N; Chiang YT; Cohn JN
    Eur J Heart Fail; 2004 Dec; 6(7):937-45. PubMed ID: 15556056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant angiotensin AT1 receptor antagonism and neprilysin inhibition produces omapatrilat-like antihypertensive effects without promoting tracheal plasma extravasation in the rat.
    Hegde LG; Yu C; Renner T; Thibodeaux H; Armstrong SR; Park T; Cheruvu M; Olsufka R; Sandvik ER; Lane CE; Budman J; Hill CM; Klein U; Hegde SS
    J Cardiovasc Pharmacol; 2011 Apr; 57(4):495-504. PubMed ID: 21297495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin receptor blocker added to previous antihypertensive agents on arteries of diabetic hypertensive patients.
    Savoia C; Touyz RM; Endemann DH; Pu Q; Ko EA; De Ciuceis C; Schiffrin EL
    Hypertension; 2006 Aug; 48(2):271-7. PubMed ID: 16785331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal protective effect of RAAS blockade across the renal continuum, with a review of the efficacy and safety of valsartan.
    Locatelli F; Palmer BF; Kashihara N; Ecder T
    Curr Med Res Opin; 2009 Dec; 25(12):2933-49. PubMed ID: 19835466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACE inhibitor- versus angiotensin II blocker-induced cough and angioedema.
    Pylypchuk GB
    Ann Pharmacother; 1998 Oct; 32(10):1060-6. PubMed ID: 9793599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can angiotensin II receptor blockers be used in patients who have developed a cough or angioedema as a result of taking an ACE inhibitor?
    Vidt DG
    Cleve Clin J Med; 2001 Mar; 68(3):189-90. PubMed ID: 11263845
    [No Abstract]   [Full Text] [Related]  

  • 19. [Angioedema and urticarial reaction induced by valsartan].
    de la Serna Higuera C
    Med Clin (Barc); 2000 Apr; 114(15):599. PubMed ID: 10846683
    [No Abstract]   [Full Text] [Related]  

  • 20. A drug safety evaluation of valsartan.
    Fogari R; Zoppi A
    Expert Opin Drug Saf; 2011 Mar; 10(2):295-303. PubMed ID: 21142805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.